Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis

Darin L Wiesner1, Oleksandr Moskalenko, Jennifer M Corcoran

  • 1Department of Microbiology, Medical School, University of Minnesota, Minneapolis, Minnesota, USA.

Mbio
|September 28, 2012
PubMed
Abstract

Insights

Cryptococcal meningitis (CM) in AIDS patients is linked to fungal strain variations. Specific genotypes, like Burst group 1, are associated with higher mortality and distinct immune responses, suggesting genotype impacts disease outcomes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Cryptococcal meningitis (CM) is a leading cause of death in individuals with AIDS, particularly in sub-Saharan Africa.
  • While virulence factors are known, the influence of Cryptococcus neoformans strain genotype on disease progression and patient outcomes remains unclear.

Purpose of the Study:

  • To investigate the association between Cryptococcus neoformans strain genotypes and clinical outcomes in Ugandan patients with AIDS and CM.
  • To understand how fungal strain variation influences host immune responses and mortality risk.

Main Methods:

  • Analysis of 140 Cryptococcus isolates from 111 Ugandan patients with AIDS and CM.
  • Multilocus sequence typing (MLST) to characterize fungal genotypes.
  • Phylogenetic and in vitro assays (e.g., capsule shedding, cytokine release) to assess strain-specific virulence and immune responses.

Main Results:

  • Identified 15 sequence types and 4 clonal clusters among the isolates, with 107 Cryptococcus neoformans var. grubii and 8 hybrid strains.
  • Patient mortality was significantly associated with different evolutionary groups (P = 0.04), with highest mortality in Burst group 1, Burst group 2, and hybrid strains.
  • Burst group 1 strains showed higher mortality (P = 0.02), increased capsule shedding (P = 0.02), and a more pronounced Th2 immune response (P = 0.02) compared to Burst group 3.

Conclusions:

  • Cryptococcal strain genotype is a significant determinant of human immune responses and mortality in CM.
  • Understanding strain variation can help predict disease outcomes and guide the development of targeted treatment strategies.
  • Genotypic information may lead to improved management of cryptococcal infections in HIV-infected individuals.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...